BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30130445)

  • 1. Herpes zoster vaccination in systemic lupus erythematosus: the current status.
    Mok CC
    Hum Vaccin Immunother; 2019; 15(1):45-48. PubMed ID: 30130445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial.
    Park JK; Kim M; Jung JI; Kim JY; Jeong H; Park JW; Winthrop KL; Lee EB
    Lancet Rheumatol; 2024 Jun; 6(6):e352-e360. PubMed ID: 38710192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pain in herpes zoster: Prevention and treatment].
    Calvo-Mosquera G; González-Cal A; Calvo-Rodríguez D; Primucci CY; Plamenov-Dipchikov P
    Semergen; 2017; 43(4):318-327. PubMed ID: 27053513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of herpes zoster by vaccination].
    Kofoed K; Rønholt F; Gerstoft J; Sand C
    Ugeskr Laeger; 2011 Jan; 173(2):110-4. PubMed ID: 21219841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes zoster vaccine: a protection for the elderly.
    Di Pietro A; Facciolà A; Visalli G
    Ann Ig; 2018; 30(4 Supple 1):23-27. PubMed ID: 30062376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes zoster vaccination in SLE: a pilot study of immunogenicity.
    Guthridge JM; Cogman A; Merrill JT; Macwana S; Bean KM; Powe T; Roberts V; James JA; Chakravarty EF
    J Rheumatol; 2013 Nov; 40(11):1875-80. PubMed ID: 24037550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention.
    Lecrenier N; Beukelaers P; Colindres R; Curran D; De Kesel C; De Saegher JP; Didierlaurent AM; Ledent EY; Mols JF; Mrkvan T; Normand-Bayle M; Oostvogels L; Da Silva FT; Vassilev V; Vinals C; Brecx A
    Expert Rev Vaccines; 2018 Jul; 17(7):619-634. PubMed ID: 30028651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the Persistence of Herpes Zoster Vaccine Efficacy in Clinical Trials.
    Cook SJ; Flaherty DK
    Clin Ther; 2015 Nov; 37(11):2388-97. PubMed ID: 26602282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Effectiveness and Safety of a Live-Attenuated Herpes Zoster Vaccine: A Comprehensive Review.
    Ansaldi F; Trucchi C; Alicino C; Paganino C; Orsi A; Icardi G
    Adv Ther; 2016 Jul; 33(7):1094-104. PubMed ID: 27262452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immune response of a live-attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomised placebo-controlled trial.
    Mok CC; Chan KH; Ho LY; Fung YF; Fung WF; Woo PCY
    Ann Rheum Dis; 2019 Dec; 78(12):1663-1668. PubMed ID: 31530556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination for preventing postherpetic neuralgia.
    Chen N; Li Q; Zhang Y; Zhou M; Zhou D; He L
    Cochrane Database Syst Rev; 2011 Mar; (3):CD007795. PubMed ID: 21412911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes zoster: vaccination status and virtuous experiences.
    Cocchio S; Gallo T; Baldo V
    Minerva Med; 2020 Feb; 111(1):4-8. PubMed ID: 32286762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against herpes-zoster: a new strategy for post-herpetic neuralgia].
    Gil de Miguel A
    An R Acad Nac Med (Madr); 2009; 126(1):57-66; discussion 67-72. PubMed ID: 20432659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of herpes zoster among patients with systemic lupus erythematosus.
    Chakravarty EF; Michaud K; Katz R; Wolfe F
    Lupus; 2013 Mar; 22(3):238-44. PubMed ID: 23257402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes zoster subunit vaccine for the prevention of herpes zoster.
    Symoniak MR; Farrokh P; Gandhi MA; Slish JC
    Am J Health Syst Pharm; 2018 Jun; 75(12):861-869. PubMed ID: 29880523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of herpes zoster and postherpetic neuralgia].
    Hüning S; von Dücker L; Kohl WK; Nashan D
    Hautarzt; 2019 Aug; 70(8):645-656. PubMed ID: 31270550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.
    Johnson RW
    Aging Clin Exp Res; 2009 Jun; 21(3):236-43. PubMed ID: 19571648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis, treatment and prophylaxis of herpes zoster].
    Ehrenstein B
    Z Rheumatol; 2020 Dec; 79(10):1009-1017. PubMed ID: 33141244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.